Navigation Links
Study reveals how cells destroy faulty proteins in cystic fibrosis

The cellular system that degrades faulty proteins created by the cystic fibrosis gene has been identified by University of North Carolina at Chapel Hill scientists. Turning off the degradation system allows some proteins to regain their proper shape, offering a new avenue for treatments aimed at curing the disease.

Cystic fibrosis (CF) is a fatal disease caused by a defective gene that produces a misshapen form of the protein cystic fibrosis transmembrane conductance regulator (CFTR). People with cystic fibrosis do not have enough CFTR for their cells to work normally because their bodies quickly destroy the mutant protein.

"Most cases of CF are caused by the inability of faulty CFTR to get in the correct shape, which leads cells to place it in the trash bin," said senior author Dr. Douglas Cyr, professor of cell and developmental biology at UNC School of Medicine. "Our research helps define the basic mechanism for CF and identify targets for the development of therapeutics designed to get CFTR into shape and allow it function normally in the lung," Cyr said.

The results, published Aug. 11, 2006, in the journal Cell, point to several possible targets for the development of new treatments aimed at stopping the disease, the researchers said.

Scientists have known for some time that treatment of cultured cells with compounds known as chemical chaperones can increase the fitness of misshaped CFTR and get it into proper shape. Thus, "If we can figure out how to get CFTR into the right shape, we can cure the disease," Cyr said.

To better understand how to fix CFTR, Cyr's research team at the UNC Cystic Fibrosis Pulmonary Research and Treatment Center focused on identifying the cellular system that disposes of faulty CFTR. The investigators identified cell components that specifically recognizes misshapen CFTR and drops it in the molecular trash bin. The team found that turning off these components ?the cell's trash coll
'"/>

Source:University of North Carolina School of Medicine


Page: 1 2

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works

Post Your Comments:
(Date:11/24/2009)...a matter of debate. A high-profile study a few yea...f their carbon from trees and leaves, evidence for...atic ecosystems. , But new research from the Uni...be true. Algae provide a much richer diet for fish...lished this week in the Proceedings of the Nation...
(Date:11/23/2009)...23, 2009 Applied mathematicians dissected the mor... a characteristic long leaf with a saddle-like arc...dges. The simple cause of the lily,s fan-like shap...differential growthwas revealed by using an equall...aiyi Liang, a postdoctoral student at Harvard,s Sc...
(Date:11/23/2009)...provides "incontrovertible evidence" that the volc...ra about 73,000 years ago deforested much of centr...earchers report. , The volcano ejected an estima...e, leaving a crater (now the world,s largest volca...eters wide. Ash from the event has been found in I...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 1Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 2Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 3Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review 49849 4New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 1New theraplex SA FACIAL PEEL Shows True Colors at Cosmetic Boot Camp 49847 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 1Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 2Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 3Micro Businesses Offer Strong Opinions On Health Reform Proposals 49845 4
...st clinical evidence that gene therapy reduces sym...portant milestone for this promising treatment whi...ed in the February issue of the journal Human Gen...atients with severe rheumatoid arthritis conducted...ael Deaconess Medical Center (BIDMC). , Original...
...globe, the demand for water is increasing with the...reas are requiring more water for drinking, sanita...n water supplies. In addition, depleting ground wa...hange have led to an increased importance for the ...ent water pollution, and efficiently allocate wate...
...thousands of lives a year, University of Utah Scho... vessel disorder leading to unpredictable, sometim... or other problems is treatable with the same stat...igh cholesterol. , If the results of a study in m...atins could provide a safe, inexpensive treatment ...
Other Biology News:Gene therapy demonstrates benefit in patients with rheumatoid arthritis 2Gene therapy demonstrates benefit in patients with rheumatoid arthritis 3How to move agriculture forward with limited water 2Statins may treat blood vessel disorder that can lead to fatal strokes 2Statins may treat blood vessel disorder that can lead to fatal strokes 3
(Date:11/24/2009)... , REYKJAVIK, Iceland, November 24 ...asdaq: DCGN ) today announced that it has received...in the company,s common stock will be,suspended as...led with the,Securities and Exchange Commission, w...g on Nasdaq, unless the company files an appeal to...
(Date:11/24/2009)..., SAN MATEO, Calif., Nov. 24 /PRNewswire-FirstC...rmaceutical company focused on developing and comm...nced today that Anthony DiTonno, President and Chi...he 21st Annual Piper Jaffray Health Care Conferenc...alace Hotel in New York, New York. ,, Mr. DiTo...
(Date:11/24/2009)..., TSX VENTURE: HTL , TORONTO, Nov. 24 /PRNews...), formerly Calotto Capital Inc., a leading provid...he stem cell research and fertility clinic markets... for the third quarter ended September 30, 2009. ,...46 million compared with $1.43 million in Q3 2008,...
(Date:11/24/2009)... Program Connects Customers with Par...lected with DNA Genotek Products , ... DNA Genotek , a leading provider of products for ...eparation, today announced its new global partner ...ts for DNA Genotek,s partner community and is desi...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10DNA Genotek Launches Global Partner Program 2DNA Genotek Launches Global Partner Program 3
...t. 15 Symmetry Medical Inc.,(NYSE: SMA ), a lead...,orthopedic device industry and other medical mark...t and Chief Executive Officer, is scheduled to,pre... The Grand Hyatt New,York in New York City on Thur...e Web cast of the presentation will be available o...
... Sept. 15 Assay Designs and the Spinal,Muscular A...nce a,collaborative agreement for development of r... protein to expedite drug discovery and developmen...eading genetic cause of,mortality in infants and t...ve been selected by the SMA Foundation, and to hel...
...5 Enobia Pharma, an emerging biotech,company focu...one,disorders, presented pre-clinical data demonst...or hypophosphatasia appears to heal bones that,hav...arlier pre-clinical,data showed that ERT with Enob...vival and prevents bone hypomineralization associa...
Other Biology Technology:Symmetry Medical to Present at UBS Global Life Sciences Conference 2Assay Designs(TM), Inc. and the Spinal Muscular Atrophy Foundation Announce Collaboration To Accelerate the Discovery of New Therapeutics for Spinal Muscular Atrophy (SMA) 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 2Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice 3
...s constitute the principal excitatory neurotransmi...receptors exist: Ionotropic receptors, and metabot...e oligomeric complexes of various subunits (GluR1-...cium channels. Metabotropic glutamate receptors ar...
PIP Beads di-C6 PtdIns(4,5)P2 from Echelon Biosciences Inc.
Mouse Anti-D-Dimer Antibody, Unconjugated from HyTest Ltd.
...ogen corresponds to amino acids 2-105 from human S...has been successfully used in Western blot, immuno... By Western blot, this antibody detects an ~ 60 kD...s also been used in immunoprecipitation and immuno...
Biology Products: